We Should Talk: Interoperability and the NHS

IMS MAXIMSA new report calls on the Department of Health to strengthen its efforts to encourage data sharing in the NHS. Paul Cooper, IMS MAXIMS Head of Research, co-authored 'We Should Talk: Interoperability and the NHS', on behalf of Intellect, the trade association representing the UK's IT, electronics and telecoms industries. The document scrutinises the effectiveness of the Interoperability Toolkit (ITK) - a set of standards and frameworks designed to help the NHS across England to connect IT systems with one another.

The report praises much about the ITK, especially its recognition that the greatest benefits can be achieved at a local level, and that some interoperability is better than none. It goes on to recommend that far more needs to be done to engage suppliers and says a major drive is needed to persuade many people within the NHS that interoperability is vital to the success of their organisations.

Paul Cooper said: "There is a huge problem in the NHS because many of the IT systems cannot talk to each other. This means that staff often can't get access to the information they need. Clinicians can only do the best for patients if they have all the relevant information about their conditions, and hospitals can only deliver efficient services if they have the data to identify bottlenecks in their systems or areas of waste.

"An efficient healthcare system, which delivers the best for patients and makes effective use of resources, can only exist if data can be shared within and between organisations. The good news is that these problems can be overcome and that everyone within the healthcare IT sector accepts that interoperability is the way forward. But too many people in the NHS still see interoperability as a technical matter rather than something which allows them to do their jobs better.

"The ITK initiative must do more to persuade everyone from medical and nursing directors, to FDs and CEOs that this is a mission critical issue. Suppliers provide what trusts ask for, and interoperability will only get to the top of the agenda if it's central to what the customer demands."

The report also calls for closer and more productive links to be established between the DH, the NHS, Intellect and its members. For the ITK to be a success, it argues, there must be productive and collaborative engagement with suppliers.

We Should Talk: Interoperability and the NHS, was written by Paul Cooper of IMS MAXIMS and Martin Whittaker of the Touchstone Consultancy, both of whom are members of the Intellect Healthcare Council. It was published in September 2011 and can be downloaded at http://www.intellectuk.org/component/docman/doc_download/5564-we-should-talk-interoperability-and-the-nhs-sept-2011.

About IMS MAXIMS
IMS MAXIMS is the company behind the widely-used MAXIMS clinical PAS. It is a specialist in developing clinical and administrative software solutions and currently supports more than 100 organisations and 10,000 users of IMS MAXIMS products.

To find out more about IMS MAXIMS and its products visit www.imsmaxims.com.

About the MAXIMS clinical PAS
MAXIMS gives clinicians the applications they need to provide the best possible patient care, and allows provider organisations to manage their patient administration with ease and efficiency. Rival products often tend to be administrative systems with clinical software added on. MAXIMS is equally focused on the needs of clinicians and provider organisations - which we believe is the way to guarantee the best patient outcomes with optimum efficiency.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...